Ashley A. Merlino

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation

Jiehui Deng, Eric S. Wang, Russell W. Jenkins et al. · Cancer Discovery · 2017 · 741 citations · Full text

<i>Ex Vivo</i> Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

Russell W. Jenkins, Amir Reza Aref, Patrick H. Lizotte et al. · Cancer Discovery · 2017 · 552 citations · Full text

Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRAS

Shunsuke Kitajima, Hajime Asahina, Ting Chen et al. · Cancer Cell · 2018 · 71 citations · Full text

Signal Transduction, Autoimmune Disease, Mek Inhibition Downstream +11

Assessing Therapeutic Efficacy of MEK Inhibition in a KRASG12C-Driven Mouse Model of Lung Cancer

Shuai Li, Shengwu Liu, Jiehui Deng et al. · Clinical Cancer Research · 2018 · 67 citations · Full text

Gemcitabine and Chk1 Inhibitor AZD7762 Synergistically Suppress the Growth of Lkb1-Deficient Lung Adenocarcinoma

Yan Liu, Yuyang Li, Xiaoen Wang et al. · Cancer Research · 2017 · 34 citations · Full text